NEW YORK (GenomeWeb News) – Interleukin Genetics said today that it has signed an agreement allowing members of Amway Global to sell some of its genetic tests, and that Amway will help in marketing the tests through its organization.

The agreement covers Interleukin Genetics' Inherent Health testing line, including tests for weight management, heart health, nutrition, and bone health.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.